ARTICLE | Management Tracks
Lilly Asia’s Li joins AffaMed as president; plus moves at Actimed, Elicio, Life Biosciences, OncoNano, Tollys, HighTide and Patient Square Capital
February 3, 2021 1:13 AM UTC
China-based in-licensing company AffaMed Therapeutics (Shanghai) Co. Ltd. hired Ji Li as president. Li was most recently a venture partner at Lilly Asia Ventures, and prior to that served as EVP and global head of business development at BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160).
Cachexia company Actimed Therapeutics Ltd. hired Frank Misselwitz as CMO. He joins from Bayer AG (Xetra:BAYN), where he was a corporate vice president and therapeutic area head for hemophilia A...